US Stock MarketDetailed Quotes

Ultragenyx Pharmaceutical (RARE)

Watchlist
  • 23.150
  • 0.0000.00%
Close Apr 8 16:00 ET
  • 21.880
  • -1.271-5.49%
Post 20:01 ET
2.28BMarket Cap-3.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical (RARE) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Research, development and commercialization of its products673M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
North America377M56.02%
Latin America170M25.26%
Europe, Middle East, and Africa108M16.05%
Asia-Pacific18M2.67%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.68%
Sample Name
Sample Code
 +16.26%
Sample Name
Sample Code
 +13.08%
4
United Sts Brent Oil Fd Lp Unit
BNO
+10.72%
5
ProShares Ultra Energy
DIG
+9.35%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.90%
Sample Name
Sample Code
 +14.44%
Sample Name
Sample Code
 +13.72%
4
ASE Technology
ASX
+11.35%
5
Kingsoft Cloud
KC
+9.51%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -